|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.40 USD | +3.16% |
|
+2.75% | -27.56% |
| 07-13 | Amphastar Pharmaceuticals, Inc. Announces Board Changes, Effective July 9, 2026 | CI |
| 07-08 | Amphastar Unit Receives US FDA Warning Letter on Violations at California Facility | MT |
Company Valuation: Amphastar Pharmaceuticals, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,114 | 1,354 | 2,963 | 1,785 | 1,231 | 829.2 | - | - |
| Change | - | 21.52% | 118.8% | -39.75% | -31.07% | -32.62% | - | - |
| Enterprise Value (EV) 1 | 1,114 | 1,354 | 2,963 | 2,235 | 1,231 | 1,140 | 1,003 | 866.8 |
| Change | - | 21.52% | 118.8% | -24.56% | -44.95% | -7.37% | -12.05% | -13.54% |
| P/E | 18.6x | 16.1x | 23.8x | 12.1x | 13.2x | 14x | 10.7x | 11.7x |
| PBR | - | - | - | 2.41x | 1.55x | 0.93x | - | - |
| PEG | - | 0.4x | 0.5x | 0.7x | -0.4x | -0.4x | 0.3x | -1.37x |
| Capitalization / Revenue | 2.55x | 2.71x | 4.6x | 2.44x | 1.71x | 1.11x | 1.07x | 1.02x |
| EV / Revenue | 2.55x | 2.71x | 4.6x | 3.05x | 1.71x | 1.53x | 1.29x | 1.07x |
| EV / EBITDA | 11.2x | 9.21x | 10.4x | 7.18x | 4.97x | 5.46x | 4.46x | 3.71x |
| EV / EBIT | 14.5x | 11.1x | 12.1x | 8.66x | 5.7x | 6.5x | 5.13x | 4.13x |
| EV / FCF | - | 20.8x | - | 13x | 10.2x | 8.84x | 7.27x | 6.37x |
| FCF Yield | - | 4.81% | - | 7.71% | 9.85% | 11.3% | 13.8% | 15.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.25 | 1.74 | 2.6 | 3.06 | 2.03 | 1.34 | 1.76 | 1.61 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 437.8 | 499 | 644.4 | 732 | 719.9 | 744.1 | 778.4 | 809 |
| EBITDA 1 | 99.1 | 147.1 | 283.9 | 311.1 | 247.5 | 208.7 | 224.8 | 233.6 |
| EBIT 1 | 76.9 | 121.8 | 245.8 | 258.2 | 215.9 | 175.5 | 195.4 | 209.7 |
| Net income 1 | 62.12 | 91.39 | 137.5 | 159.5 | 98.09 | 64 | 84 | 79 |
| Net Debt 1 | - | - | - | 450 | - | 310.7 | 173.4 | 37.64 |
| Reference price 2 | 23.29 | 28.02 | 61.85 | 37.13 | 26.78 | 18.80 | 18.80 | 18.80 |
| Nbr of stocks (in thousands) | 47,849 | 48,331 | 47,907 | 48,081 | 45,952 | 44,093 | - | - |
| Announcement Date | 3/10/22 | 2/28/23 | 2/28/24 | 2/27/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 14.03x | 1.53x | 5.46x | -.--% | 829M | |
| 34.25x | 12.25x | 25.43x | 0.59% | 1,028B | |
| 27.09x | 6.22x | 16.9x | 2.1% | 611B | |
| 30.33x | 7.27x | 14.9x | 2.81% | 432B | |
| 17.47x | 4.34x | 10.68x | 3.06% | 323B | |
| 21.17x | 5.44x | 13.17x | 2.9% | 277B | |
| 20.69x | 4.37x | 12.08x | 2.02% | 257B | |
| 13.99x | 5.26x | 10.84x | 3.55% | 217B | |
| 23.3x | 6.19x | 10.94x | 2.84% | 192B | |
| -46.85x | 5.61x | 31x | 2.5% | 161B | |
| Average | 15.55x | 5.85x | 15.14x | 2.24% | 349.92B | |
| Weighted average by Cap. | 23.33x | 7.66x | 17.88x | 2.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AMPH Stock
- Valuation Amphastar Pharmaceuticals, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
